ProfileOfResearchers

Identified 445

331

TITLE: Compliance is significantly better in HAART responders compared to non-responders
AUTHORS: Vandamme, AM; Van Vaerenbergh, K; Deschamps, A; De Graeve, V; De Saar, V; Maes, B; Ceunen, H; De Smet, K; Peetermans, W; Bobbaers, H; Van Ranst, M; Desmyter, J; De Clercq, E; Van Wijngaerden, E; De Geest, S;
PUBLISHED: 2000, SOURCE: AIDS, VOLUME: 14

INDEXED IN:

WOS

IN MY:

ORCID |

ResearcherID

332

TITLE: Initiation of HAART in drug naive HIV-1 patients prevents viral breakthrough for up to 43 months in 60% of the patients
AUTHORS: Vandamme, AM; Van Vaerenbergh, K; Schmit, JC; Schmidt, B; Walter, H; Fontaine, E; Schmitt, M; Van Laethem, K; Rascu, A; De Vroey, V; Grunke, M; Low, P; Van Ranst, M; Desmyter, J; De Clercq, E; Harrer, T;
PUBLISHED: 2000, SOURCE: AIDS, VOLUME: 14

INDEXED IN:

WOS

IN MY:

ORCID |

ResearcherID

333

TITLE: Non-adherence to HAART: clinically relevant patient categorisation based on electronic event monitoring
AUTHORS: Van Wijngaerden, E; De Saar, V; De Graeve, V; Vandamme, AM; Van Vaerenbergh, K; Bobbaers, H; Deschamps, A; Ceunen, H; De Geest, S;
PUBLISHED: 2000, SOURCE: AIDS, VOLUME: 14

INDEXED IN:

WOS

IN MY:

ORCID |

ResearcherID

334

TITLE: Evaluation of two commercial kits for the detection of genotypic drug-resistance on a panel of HIV-1 subtypes A-J
AUTHORS: Fontaine, E; Riva, C; Peeters, M; Schmit, JC; Delaporte, E; Van Laethem, K; Van Vaerenbergh, K; Van Wijngaerden, E; Van Ranst, M; Vandamme, AM;
PUBLISHED: 2000, SOURCE: AIDS, VOLUME: 14

INDEXED IN:

WOS

IN MY:

ORCID |

ResearcherID

335

TITLE: Performance of the new ViroSeq (TM) HIV-1 genotyping system (version 2) with group M subtype panel and with subtype B clinical samples at test sites
AUTHORS: Dileanis, J; Marlowe, N; Hoo, B; Brown, RC; Buimer, M; Huang, D; Palumbo, F; Schuurman, R; Van Laethem, K; Vandamme, AM; Elbeik, T;
PUBLISHED: 2000, SOURCE: AIDS, VOLUME: 14

INDEXED IN:

WOS

IN MY:

ORCID |

ResearcherID

336

TITLE: Phenotypic multi-nucleoside resistance linked to the Q151M mutation is enhanced under the selective pressure of acyclic nucleotide analogs but reduced by foscarnet
AUTHORS: Van Laethem, K; Witvrouw, M; Pannecouque, C; Van Remoortel, B; Esnouf, R; Balzarini, J; Desmyter, J; De Clercq, E; Vandamme, AM;
PUBLISHED: 2000, SOURCE: AIDS, VOLUME: 14

INDEXED IN:

WOS

IN MY:

ORCID |

ResearcherID

337

TITLE: Growing divergence inside primate T cell lymphotropic viruses [Groeiende divergentie binnen de primaat T-cell lymfotrope virussen.]
AUTHORS: Van Brussel, M; Vandamme, AM;
PUBLISHED: 1999, SOURCE: Verhandelingen - Koninklijke Academie voor Geneeskunde van België, VOLUME: 61, ISSUE: 1

INDEXED IN:

Scopus

IN MY:

ORCID

338

TITLE: Phenotypic assays and sequencing are less sensitive than point mutation assays for detection of resistance in mixed HIV-1 genotypic populations
AUTHORS: Van Laethem, K; Van Vaerenbergh, K; Schmit, JC; Sprecher, S; Hermans, P; De Vroey, V; Schuurman, R; Harrer, T; Witvrouw, M; Van Wijngaerden, E; Stuyver, L; Van Ranst, M; Desmyter, J; De Clercq, E; Vandamme, AM;
PUBLISHED: 1999, SOURCE: JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, VOLUME: 22, ISSUE: 2

INDEXED IN:

Scopus

WOS

IN MY:

ORCID |

ResearcherID

339

TITLE: Third International Workshop on HIV Drug Resistance and Treatment Strategies, San Diego, USA, 23-26 June 1999: Highlights
AUTHORS: Vandamme, AM;
PUBLISHED: 1999, SOURCE: International Antiviral News, VOLUME: 7, ISSUE: 6

INDEXED IN:

Scopus

IN MY:

ORCID